Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 20,200 | 30,799 | 39,504 | 28,229 | 10,105 |
| Operating Income | -20,200 | -30,799 | -39,504 | -28,229 | -10,105 |
| Interest Expense | 13 | 19 | 34 | 0 | 0 |
| Other Income | 367 | 918 | 293 | -12 | 1,589 |
| Pre-tax Income | -19,846 | -29,899 | -39,244 | -28,241 | -8,516 |
| Income Tax | 19 | 20 | 17 | 21 | 6 |
| Net Income Continuous | -19,865 | -29,919 | -39,261 | -28,261 | -8,522 |
| Net Income | $-19,865 | $-29,919 | $-39,261 | $-28,261 | $-8,522 |
| EPS Basic Total Ops | -5.48 | -17.73 | -33.00 | -29.00 | -11.60 |
| EPS Basic Continuous Ops | -5.48 | -17.73 | -33.00 | -28.96 | -11.52 |
| EPS Diluted Total Ops | -5.48 | -17.73 | -33.00 | -29.00 | -11.60 |
| EPS Diluted Continuous Ops | -5.48 | -17.73 | -33.00 | -28.96 | -11.52 |
| EPS Diluted Before Non-Recurring Items | N/A | -18.00 | -33.00 | -25.00 | -13.80 |
| EBITDA(a) | $-20,200 | $-30,799 | $-39,504 | $-28,229 | $-10,105 |